Showing results (1511-1520 of 1,606) with videos related to

Sort By:
Pageof 161
International Journal of Cancer|November 29, 2018
Application of patient-derived liver cancer cells for phenotypic characterization and therapeutic target identificationDarko Castven, Diana Becker, Carolin Czauderna, et al.
Science (New York, N.Y.)|March 12, 2021
Lipid presentation by the protein C receptor links coagulation with autoimmunityNadine Müller-Calleja, Anne Hollerbach, Jennifer Royce, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 18, 2016
Role of the GALAD and BALAD-2 Serologic Models in Diagnosis of Hepatocellular Carcinoma and Prediction of Survival in PatientsSarah Berhane, Hidenori Toyoda, Toshifumi Tada, et al.
Zeitschrift Fur Rheumatologie|August 19, 2016
[The regional network ADAPTHERA : Rheumatology care through coordinated cooperation: comprehensive, trans-sectoral, covering all health insurance. Initial results]A Schwarting, B Pfeiff, C Amberger, et al.
Journal of Medicinal Chemistry|April 15, 2016
Discovery and Characterization of a Highly Potent and Selective Aminopyrazoline-Based in Vivo Probe (BAY-598) for the Protein Lysine Methyltransferase SMYD2Erik Eggert, Roman C Hillig, Silke Koehr, et al.
The Lancet. Infectious Diseases|February 27, 2025
Efficacy and safety of sipavibart for prevention of COVID-19 in individuals who are immunocompromised (SUPERNOVA): a randomised, controlled, double-blind, phase 3 trialGhady Haidar, Steven Thomas, Paul Loubet, et al.
Transplantation|January 10, 2024
Potential and Uncertainties of RejectClass in Acute Kidney Graft Dysfunction: An Independent Validation StudyFriedrich A von Samson-Himmelstjerna, Nassim Kakavand, Charlotte Gleske, et al.
Oncology Letters|August 27, 2025
Radiomics-based prediction of HCC response to atezolizumab/bevacizumabIsaac Rodriguez, Abhinay Vellala, Timo Itzel, et al.
Frontiers in Oncology|March 3, 2023
Outcomes of beta blocker use in advanced hepatocellular carcinoma treated with immune checkpoint inhibitorsY Linda Wu, Grace van Hyfte, Umut Özbek, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 19, 2026
Liver Transplantation After Immune Checkpoint Inhibition in Hepatocellular Carcinoma-Data From the Multinational LITCHI RegistryUlrike Bauer, Maria R Troppmair, Najib Ben Khaled, et al.
Pageof 161